These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9210893)

  • 41. [Advances of drug resistance marker of gemcitabine for non-small cell lung cancer].
    Chen Y; Qian X; Liu B
    Zhongguo Fei Ai Za Zhi; 2011 May; 14(5):421-8. PubMed ID: 21569648
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Topoisomerase I inhibitors and other new cytotoxic drugs.
    Verweij J
    Eur J Cancer; 1995; 31A(5):828-30. PubMed ID: 7640070
    [No Abstract]   [Full Text] [Related]  

  • 43. In vivo chemotherapeutic profile of human gallbladder small cell carcinoma.
    Nishime C; Ohnishi Y; Suemizu H; Tamaoki N; Kusumi T; Sato F; Yamazaki H; Nakamura M; Ueyama Y; Kijima H
    Biomed Res; 2008 Oct; 29(5):251-6. PubMed ID: 18997440
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral cytotoxic drugs.
    Gridelli C; Rossi A; Guerriero C; Nicolella D; Ferrara C; Del Gaizo F; Colantuoni G; Airoma G; Maione P
    Suppl Tumori; 2002; 1(4):S19-23. PubMed ID: 12415809
    [No Abstract]   [Full Text] [Related]  

  • 45. [From ASCO and WCLC 2005 to clinical practice: "conventional" treatments].
    Fournel P
    Rev Pneumol Clin; 2006 Feb; 62 Spec no 1():1S25-9. PubMed ID: 16719153
    [No Abstract]   [Full Text] [Related]  

  • 46. [Phase II study].
    Niitani H
    Gan To Kagaku Ryoho; 1995 Apr; 22(5):607-10. PubMed ID: 7717711
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Developed new agents for lung cancer].
    Kato Y; Saijo N
    Nihon Geka Gakkai Zasshi; 2002 Feb; 103(2):218-23. PubMed ID: 11904983
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Irinotecan in advanced lung cancer: focus on North American trials.
    Langer CJ
    Oncology (Williston Park); 2004 Jun; 18(7 Suppl 4):17-28. PubMed ID: 15255164
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Chemotherapy for elderly patients with lung cancer].
    Okamoto H; Watanabe K
    Nihon Rinsho; 2002 May; 60 Suppl 5():591-5. PubMed ID: 12101743
    [No Abstract]   [Full Text] [Related]  

  • 50. A pharmacogenomic study of docetaxel and gemcitabine for the initial treatment of advanced non-small cell lung cancer.
    Petty WJ; Knight SN; Mosley L; Lovato J; Capellari J; Tucker R; Blackstock AW; Miller MS; Miller AA
    J Thorac Oncol; 2007 Mar; 2(3):197-202. PubMed ID: 17410042
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemotherapy in metastatic non-small-cell lung cancer.
    Sandler A
    Oncology (Williston Park); 2000 Jul; 14(7 Suppl 5):15-27. PubMed ID: 10981287
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Single-agent gemcitabine and gemcitabine/irinotecan combination (irimogem) in non-small cell lung cancer.
    Rocha Lima CM; Eckardt JR; Leong SS; Sherman CA; Perkel JA; Putman T; Safa AR; Bahadori HR; Green MR
    Semin Oncol; 1999 Oct; 26(5 Suppl 16):43-50; discussion 71-2. PubMed ID: 10585008
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New drugs in non-small cell lung cancer. An overview.
    Giaccone G
    Lung Cancer; 1995 Apr; 12 Suppl 1():S155-62. PubMed ID: 7551924
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chemotherapy for non-small cell lung cancer: have we reached a new plateau?
    Shepherd FA
    Semin Oncol; 1999 Feb; 26(1 Suppl 4):3-11. PubMed ID: 10201515
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of Single Agent Gemcitabine and Docetaxel in Second-Line Therapy for Advanced Stage Non-Small Cell Lung Cancer in a University Hospital in Turkey.
    Yıldırım F; Baha A; Yurdakul AS; Ozturk C
    Asian Pac J Cancer Prev; 2015; 16(17):7859-65. PubMed ID: 26625811
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Designing geriatric-specific trials in advanced lung cancer: What, who and how to study?
    Gajra A
    J Geriatr Oncol; 2017 Jan; 8(1):16-17. PubMed ID: 27993461
    [No Abstract]   [Full Text] [Related]  

  • 57. Efficacy of cancer chemotherapy in relation to the pretreatment number of lymphocytes in patients with metastatic solid tumors.
    Lissoni P; Brivio F; Fumagalli L; Messina G; Ghezzi V; Frontini L; Giani L; Vaghi M; Ardizzoia A; Gardani GS
    Int J Biol Markers; 2004; 19(2):135-40. PubMed ID: 15255546
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review.
    Clegg A; Scott DA; Hewitson P; Sidhu M; Waugh N
    Thorax; 2002 Jan; 57(1):20-8. PubMed ID: 11809985
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Non-platinum gemcitabine combinations in non-small cell lung cancer.
    Marx G; Harper P
    Lung Cancer; 2002 Nov; 38 Suppl 2():S51-4. PubMed ID: 12431830
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current role of irinotecan in the treatment of non-small-cell lung cancer.
    Kelly K
    Oncology (Williston Park); 2002 Sep; 16(9):1153-62, 1165; discussion 1165-6 passim. PubMed ID: 12380945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.